Literature DB >> 21677690

Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus).

R Alba1, A C Bradshaw, N Mestre-Francés, J-M Verdier, D Henaff, A H Baker.   

Abstract

Coagulation factor X (FX)-binding ablated adenovirus type 5 (Ad5) vectors have been genetically engineered to ablate the interaction with FX, resulting in substantially reduced hepatocyte transduction following intravenous administration in rodents. Here, we quantify viral genomes and gene transfer mediated by Ad5 and FX-binding-ablated Ad5 vectors in non-human primates. Ad5 vectors accumulated in and mediated gene transfer predominantly to the liver, whereas FX-binding-ablated vectors primarily targeted the spleen but showed negligible liver gene transfer. In addition, we show that Ad5 binding to hepatocytes may be due to the presence of heparan sulfate proteoglycans (HSPGs) on the cell membrane. Therefore, the Ad5-FX-HSPG pathway mediating liver gene transfer in rodents is also the mechanism underlying Ad5 hepatocyte transduction in Microcebus murinus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677690      PMCID: PMC3382196          DOI: 10.1038/gt.2011.87

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  22 in total

1.  Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration.

Authors:  F A Nunes; E E Furth; J M Wilson; S E Raper
Journal:  Hum Gene Ther       Date:  1999-10-10       Impact factor: 5.695

2.  Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.

Authors:  Shaoheng Ni; Kathrin Bernt; Anuj Gaggar; Zong-Yi Li; Hans-Peter Kiem; André Lieber
Journal:  Hum Gene Ther       Date:  2005-06       Impact factor: 5.695

3.  Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.

Authors:  Raul Alba; Angela C Bradshaw; Alan L Parker; David Bhella; Simon N Waddington; Stuart A Nicklin; Nico van Rooijen; Jerome Custers; Jaap Goudsmit; Dan H Barouch; John H McVey; Andrew H Baker
Journal:  Blood       Date:  2009-05-08       Impact factor: 22.113

4.  CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.

Authors:  H Mizuguchi; N Koizumi; T Hosono; A Ishii-Watabe; E Uchida; N Utoguchi; Y Watanabe; T Hayakawa
Journal:  Gene Ther       Date:  2002-06       Impact factor: 5.250

5.  Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.

Authors:  Dmitry M Shayakhmetov; Anuj Gaggar; Shaoheng Ni; Zong-Yi Li; André Lieber
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X.

Authors:  Angela C Bradshaw; Alan L Parker; Margaret R Duffy; Lynda Coughlan; Nico van Rooijen; Veli-Matti Kähäri; Stuart A Nicklin; Andrew H Baker
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

7.  Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.

Authors:  Naoya Koizumi; Kenji Kawabata; Fuminori Sakurai; Yoshiteru Watanabe; Takao Hayakawa; Hiroyuki Mizuguchi
Journal:  Hum Gene Ther       Date:  2006-03       Impact factor: 5.695

8.  Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.

Authors:  Oday Hamid; Mary L Varterasian; Scott Wadler; J Randolph Hecht; Al Benson; Evanthia Galanis; Margaret Uprichard; Charles Omer; Paul Bycott; Robert C Hackman; Anthony F Shields
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

9.  The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer.

Authors:  E Wisse; F Jacobs; B Topal; P Frederik; B De Geest
Journal:  Gene Ther       Date:  2008-04-10       Impact factor: 5.250

10.  Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.

Authors:  H A Jaffe; C Danel; G Longenecker; M Metzger; Y Setoguchi; M A Rosenfeld; T W Gant; S S Thorgeirsson; L D Stratford-Perricaudet; M Perricaudet
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

View more
  20 in total

1.  FX and host defense evasion tactics by adenovirus.

Authors:  Andrew H Baker; Stuart A Nicklin; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2013-06       Impact factor: 11.454

2.  The Inflammatory and Fibrotic Patterns of Hepatic Stellate Cells Following Coagulation Factors (VII or X)-Shielded Adenovirus Infection.

Authors:  Alireza Shiri; Jamal Sarvari; Saeed Firoozi Ghahestani; Nasser Gholijani; Ali Mohammad Tamaddon; Mahroo Rastegari; Afagh Moattari; Seyed Younes Hosseini
Journal:  Curr Microbiol       Date:  2021-01-07       Impact factor: 2.188

3.  Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells.

Authors:  Annasara Lenman; Steffen Müller; Mari I Nygren; Lars Frängsmyr; Thilo Stehle; Niklas Arnberg
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

4.  Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.

Authors:  Jiangtao Ma; Margaret R Duffy; Lin Deng; Rachel S Dakin; Taco Uil; Jerome Custers; Sharon M Kelly; John H McVey; Stuart A Nicklin; Andrew H Baker
Journal:  PLoS Pathog       Date:  2015-02-06       Impact factor: 6.823

5.  Rapamycin enhances adenovirus-mediated cancer imaging and therapy in pre-immunized murine hosts.

Authors:  Ziyue Karen Jiang; Mai Johnson; Diana L Moughon; Jennifer Kuo; Makoto Sato; Lily Wu
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

6.  Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery.

Authors:  Lynda Coughlan; Angela C Bradshaw; Alan L Parker; Hollie Robinson; Katie White; Jerome Custers; Jaap Goudsmit; Nico Van Roijen; Dan H Barouch; Stuart A Nicklin; Andrew H Baker
Journal:  Mol Ther       Date:  2012-08-28       Impact factor: 11.454

7.  Transduction Enhancers Enable Efficient Human Adenovirus Type 5-Mediated Gene Transfer into Human Multipotent Mesenchymal Stromal Cells.

Authors:  Robin Nilson; Olivia Lübbers; Linus Weiß; Karmveer Singh; Karin Scharffetter-Kochanek; Markus Rojewski; Hubert Schrezenmeier; Philip Helge Zeplin; Wolfgang Funk; Lea Krutzke; Stefan Kochanek; Astrid Kritzinger
Journal:  Viruses       Date:  2021-06-12       Impact factor: 5.048

8.  Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.

Authors:  Anniina Koski; Eerika Karli; Anja Kipar; Sophie Escutenaire; Anna Kanerva; Akseli Hemminki
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.

Authors:  Cong-Jun Wang; Chao-Wen Xiao; Tian-Geng You; Ya-Xin Zheng; Wei Gao; Zhu-Qing Zhou; Jun Chen; Xin-Bo Xue; Jia Fan; Hui Zhang
Journal:  Mol Cancer       Date:  2012-05-08       Impact factor: 27.401

Review 10.  The evolution of adenoviral vectors through genetic and chemical surface modifications.

Authors:  Cristian Capasso; Mariangela Garofalo; Mari Hirvinen; Vincenzo Cerullo
Journal:  Viruses       Date:  2014-02-17       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.